This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: John C Amedio, Jr: Innovator in Pyrazolo Compounds
Introduction
John C Amedio, Jr. is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of chemistry, particularly in the development of solid forms of pyrazolo[3,4-d]pyrimidine compounds. His work is essential for advancing pharmaceutical applications.
Latest Patents
Amedio holds a patent for solid forms of 6-((3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one. This patent outlines methods for preparing and utilizing these compounds, which have potential therapeutic applications.
Career Highlights
John C Amedio, Jr. is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to contribute to innovative drug development and research.
Collaborations
Amedio has collaborated with talented coworkers, including Caroline Yvette Proulx-Lafrance and Erika Volckova. These partnerships enhance the research and development efforts within his team.
Conclusion
John C Amedio, Jr. is a distinguished inventor whose work in pyrazolo compounds is paving the way for advancements in pharmaceuticals. His contributions are vital to the ongoing innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile